Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truset vs Telmisartan/Amlodipine/HCTZ in Elderly Hypertension
NCT06041529Phase 4Active, not recruiting
- Sponsor
- Yuhan
- Start
- Oct 2023
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of telmisartan, amlodipine, chlorthalidone in essential hypertension, sponsored by Yuhan. Started Oct 2023; status: active, not recruiting.
02
Drugs
telmisartanamlodipinechlorthalidone
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT06041529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06041529.